tm
Seeing Is Believing
tm
Seeing Is Believing
CNTB is currently covered by 1 analysts with an average price target of $9.92. This is a potential upside of $8.86 (835.85%) from yesterday's end of day stock price of $1.06.
Connect Biopharma Holdings Ltd's activity chart (see below) currently has 7 price targets and 8 ratings on display. The stock rating distribution of CNTB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 127 days.
Highest price target for CNTB is $1, Lowest price target is $1, average price target is $9.92.
Most recent stock forecast was given by THOMAS SMITH from LEERINK on 08-Feb-2023. First documented stock forecast 13-Apr-2021.
Currently out of the existing stock ratings of CNTB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 9 months 23 days ago
(08-Feb-2023)
0/2 (0%)
$17.35 (373.12%)
Hold
$1.75
$0.69 (65.09%)
$1.5
2 years 2 months 17 days ago
(14-Sep-2022)
2/4 (50%)
$0.37 (26.81%)
254
What is CNTB (Connect Biopharma Holdings Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on CNTB (Connect Biopharma Holdings Ltd) with a proven track record?
Which analyst has the current lower performing score on CNTB (Connect Biopharma Holdings Ltd) with a proven track record?
Which analyst has the most public recommendations on CNTB (Connect Biopharma Holdings Ltd)?
Which analyst is the currently most bullish on CNTB (Connect Biopharma Holdings Ltd)?
Which analyst is the currently most reserved on CNTB (Connect Biopharma Holdings Ltd)?
